Roivant Sciences Ltd.

ISIN BMG762791017

 | 

WKN A3C4MS

Market cap (in EUR)
25,418 m
Country
United Kingdom
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Show more Show less
Healthcare Healthcare Services Miscellaneous Healthcare United Kingdom

Financials

Key metrics

Market capitalisation, EUR 25,418 m
EPS, EUR -0.48
P/B ratio 7.0
P/E ratio 1.9
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 7 m
Net income, EUR -259 m
Profit margin -3,629.19%

What ETF is Roivant Sciences Ltd. in?

There are 28 ETFs which contain Roivant Sciences Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Roivant Sciences Ltd. is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
UBS Core MSCI World UCITS ETF USD acc 0.02%
Equity
World
12,075
iShares MSCI World UCITS ETF (Dist) 0.02%
Equity
World
8,343
Amundi MSCI World Swap II UCITS ETF Dist 0.02%
Equity
World
8,792
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) 0.06%
Equity
World
Health Care
Social/Environmental
839
Xtrackers MSCI World UCITS ETF 1D 0.02%
Equity
World
4,657
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.27%
Equity
United States
Small Cap
229
JPMorgan US Growth Equity Active UCITS ETF EUR Hedged (acc) 0.05%
Equity
United States
Growth
2
iShares MSCI USA CTB Enhanced ESG UCITS ETF USD (Dist) 0.08%
Equity
United States
Social/Environmental
15,809
iShares MSCI North America UCITS ETF 0.03%
Equity
North America
1,355
Vanguard FTSE Global Small-Cap UCITS ETF USD Dist 0.18%
Equity
World
Small Cap
11
UBS Core MSCI World UCITS ETF USD dis 0.02%
Equity
World
2,268
iShares MSCI World Screened UCITS ETF USD (Dist) 0.02%
Equity
World
Social/Environmental
970
UBS Core MSCI World UCITS ETF hGBP dis 0.02%
Equity
World
118
UBS Core MSCI USA UCITS ETF USD dis 0.03%
Equity
United States
1,429
JPMorgan US Growth Equity Active UCITS ETF USD (acc) 0.05%
Equity
United States
Growth
626
Amundi MSCI North America ESG Broad Transition UCITS ETF Dist 0.01%
Equity
North America
Social/Environmental
Climate Change
42
iShares MSCI All Country World UCITS ETF USD (Acc) 0.01%
Equity
World
31,588
iShares MSCI USA Screened UCITS ETF USD (Dist) 0.03%
Equity
United States
Social/Environmental
1,425
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.02%
Equity
World
Social/Environmental
556
UBS Core MSCI World UCITS ETF hEUR acc 0.02%
Equity
World
978
UBS Core MSCI USA UCITS ETF EUR Hedged dis 0.03%
Equity
United States
175
Vanguard FTSE Global All-Cap UCITS ETF USD Dist 0.02%
Equity
World
149
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.73%
Equity
United States
Health Care
Biotech
69
Vanguard Russell 1000 U.S. Value UCITS ETF USD Dist 0.05%
Equity
United States
Value
2
JPMorgan US Growth Equity Active UCITS ETF USD (dist) 0.05%
Equity
United States
Growth
1
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.03%
Equity
North America
Social/Environmental
31
Vanguard Russell U.S. Mid-Cap UCITS ETF USD Dist 0.14%
Equity
United States
Mid Cap
3
iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist) 0.09%
Equity
United States
Momentum
13
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.